tiprankstipranks
PTC Therapeutics (PTCT)
:PTCT
US Market

PTC Therapeutics (PTCT) Financial Statements

Compare
352 Followers

PTC Therapeutics Financial Overview

PTC Therapeutics's market cap is currently $4.36B. The company's EPS TTM is $-4.729; its P/E ratio is ―; PTC Therapeutics is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is $-1.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 806.78M$ 937.82M$ 698.80M$ 538.59M$ 380.77M
Gross Profit$ 806.78M$ 872.34M$ 654.12M$ 506.26M$ 361.82M
Operating Income$ -302.57M$ -349.40M$ -439.93M$ -374.94M$ -397.88M
EBITDA$ -120.46M$ -330.34M$ -367.78M$ -374.44M$ -297.00M
Net Income$ -363.30M$ -626.60M$ -559.02M$ -523.90M$ -438.16M
Balance Sheet
Cash & Short-Term Investments$ 1.14B$ 876.74M$ 410.70M$ 773.38M$ 1.10B
Total Assets$ 1.71B$ 1.90B$ 1.71B$ 1.94B$ 2.21B
Total Debt$ 389.30M$ 2.23B$ 703.63M$ 431.43M$ 420.44M
Net Debt$ -390.41M$ 1.64B$ 292.92M$ -341.94M$ 211.63M
Total Liabilities$ 2.80B$ 2.71B$ 2.05B$ 1.94B$ 1.73B
Stockholders' Equity$ -1.10B$ -818.55M$ -347.09M$ 1.44M$ 481.98M
Cash Flow
Free Cash Flow$ -114.19M$ -279.04M$ -509.11M$ -336.66M$ -250.05M
Operating Cash Flow$ -107.69M$ -158.42M$ -356.65M$ -251.33M$ -194.07M
Investing Cash Flow$ 44.18M$ -176.74M$ 290.18M$ 219.18M$ -561.55M
Financing Cash Flow$ 255.87M$ 646.40M$ 167.95M$ 20.88M$ 668.72M
Currency in USD

PTC Therapeutics Earnings and Revenue History

PTC Therapeutics Debt to Assets

PTC Therapeutics Cash Flow

PTC Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis